Glyphosate, the world’s most widely used herbicide, shows endocrine-disrupting activity in laboratory studies, but regulators have not officially classified it as an endocrine disruptor. The disconnect comes down to dose, formulation, and how different authorities weigh the evidence. In lab settings, glyphosate can mimic estrogen, interfere with hormone-producing enzymes, and alter reproductive development. Whether typical human exposure levels cause these same effects remains genuinely unsettled.
How Glyphosate Interferes With Hormones
Endocrine disruptors work by mimicking, blocking, or altering the body’s hormones. Glyphosate appears capable of at least two of these pathways.
The first involves estrogen mimicry. A 2022 study in breast cancer cells found that at high concentrations, glyphosate behaves like estrogen by binding to the same docking site on estrogen receptors that the body’s natural estrogen uses. It triggers the same chain of cellular events: the receptor activates, signals gene activity, and then degrades, just as it would after encountering real estrogen. The binding appears to happen through an unusual mechanism involving zinc ions that help glyphosate fit into the receptor’s pocket.
The second pathway involves an enzyme called aromatase, which converts testosterone into estrogen. This enzyme is essential for maintaining the balance between male and female sex hormones in both men and women. Research published in Environmental Health Perspectives showed that glyphosate interacts directly with the active site of aromatase. After 18 hours of exposure, commercial glyphosate formulations inhibited aromatase activity at concentrations 100 times lower than what’s used in agricultural spraying. Glyphosate alone was weaker at this, but when even tiny amounts of the surfactants found in commercial products were present, the inhibition was dramatically amplified. The enzyme’s gene expression also dropped, meaning cells produced less aromatase overall.
The Formulation Problem
This is one of the most important and least understood parts of the glyphosate debate. The glyphosate molecule by itself behaves differently than the commercial herbicide products people actually encounter. Commercial formulations contain surfactants and other ingredients designed to help glyphosate penetrate plant cells. These same ingredients also help glyphosate penetrate animal and human cells more effectively.
In the aromatase study, pure glyphosate alone was largely ineffective at disrupting enzyme activity in cell cultures. But adding just 0.02% of the surfactants found in Roundup unlocked glyphosate’s disruptive potential. The commercial formulation inhibited aromatase at concentrations three times lower than pure glyphosate could achieve. A recent review covering studies from 2010 to 2025 confirmed this pattern: co-formulants long considered inactive clearly contribute to glyphosate’s harmful effects. A meta-analysis of rodent studies similarly found that adverse effects on sperm quality were not attributed to pure glyphosate but rather to the full commercial formulations.
This matters because most regulatory safety testing focuses on glyphosate alone, while most real-world exposure involves the complete formulation.
Effects on Thyroid Hormones
Four human studies have examined whether glyphosate exposure shifts thyroid hormone levels, with mixed results. A cross-sectional study of 417 people in Thailand found that higher glyphosate exposure was associated with slight elevations in T3 and T4 (the two main thyroid hormones), with the strongest effect on total T4. A follow-up study of 48 pesticide sprayers measured hormone levels the day before and after spraying and found a significant increase in T4 of about 25.5 ng/dL.
Other studies were less definitive. A Brazilian study of farm residents found a non-significant 22% decrease in TSH (the hormone that tells the thyroid to work harder) among people recently exposed to glyphosate, along with modest, non-significant drops in T3 and T4. A U.S. study of male pesticide applicators found no significant thyroid hormone changes, though there was a borderline trend suggesting TSH might rise with greater cumulative exposure. Taken together, the thyroid evidence suggests glyphosate can nudge thyroid hormones, but the direction and magnitude aren’t consistent enough to draw firm conclusions in humans.
Reproductive and Developmental Effects
The reproductive evidence is more concerning. A U.S. population study found detectable glyphosate in the urine of roughly 82% of people tested, and researchers reported inverse correlations between urinary glyphosate levels and blood concentrations of key sex hormones in both men and women, meaning higher glyphosate was associated with lower hormone levels.
In a study of human semen from 30 healthy men living in an agricultural region of Greece, exposing sperm to glyphosate at 0.36 mg/L for just one hour reduced progressive motility, decreased overall movement, and caused DNA fragmentation. In rats, five weeks of high-dose glyphosate exposure significantly reduced total sperm count and the weight of the seminal vesicles, glands that produce a large portion of seminal fluid.
Prenatal exposure raises additional flags. A pilot study within a large U.S. pregnancy cohort measured glyphosate in second-trimester urine samples from 94 mothers. Glyphosate was detected in 95% of samples. In female newborns, higher maternal glyphosate levels were associated with longer anogenital distance, a physical measurement used as a marker of prenatal hormone exposure. This pattern, which suggests androgenic (male-hormone-like) effects, partially mirrored earlier findings in rodents exposed to commercial glyphosate formulations during pregnancy. No associations appeared in male newborns, suggesting the endocrine effects may be sex-specific.
What Regulators Have Decided
In 2023, the European Food Safety Authority completed its peer review and concluded that glyphosate does not meet the EU’s formal criteria for classification as an endocrine disruptor. This assessment led to the renewal of glyphosate’s approval for use in Europe.
That conclusion, however, doesn’t mean the science is settled. The regulatory framework evaluates glyphosate the active ingredient in isolation, while much of the concerning laboratory evidence involves commercial formulations with their surfactant packages. The criteria also require a specific chain of evidence linking a hormonal mechanism to an adverse effect in a whole organism, a bar that individual cell studies or small human studies don’t clear on their own. Critics argue the framework systematically underweights the kind of evidence that exists for glyphosate: cell-level mechanistic work, animal studies using commercial formulations, and small epidemiological studies showing associations with hormone shifts.
What This Means in Practice
The evidence sits in an uncomfortable middle ground. Glyphosate clearly interacts with the endocrine system in laboratory conditions. It binds estrogen receptors, disrupts the enzyme that balances sex hormones, and is associated with reproductive changes in both animal and small human studies. But the effects are often seen at concentrations above typical dietary exposure, are stronger with commercial formulations than with pure glyphosate, and haven’t been confirmed in large-scale human studies.
If you’re concerned about exposure, the most practical steps are washing produce thoroughly, since glyphosate is used as a pre-harvest drying agent on crops like oats and wheat, and minimizing direct skin contact with herbicide products during yard or garden use. Occupational exposure during spraying consistently produces the highest measurable levels in human studies, with detectable changes in hormone levels appearing within a single day of application work.